Medication, laboratory and diagnostic tests costs |
Pegylated interferon alfa-2a + Ribavirin (per week) |
3,150 |
630 |
Gamma |
[35] |
Pegylated interferon alfa-2b + Ribavirin (per week) |
3,150 |
630 |
Gamma |
[35] |
Investigation and monitoring |
16,277 |
3,255 |
Gamma |
[34] |
Direct medical cost for complication treatment |
Costs of chronic HCV infection (per year) |
65,640 |
19,723 |
Gamma |
[33] |
Costs of compensated cirrhosis (per year) |
73,532 |
18,605 |
Gamma |
[33] |
Costs of decompensated cirrhosis (per year) |
138,141 |
18,996 |
Gamma |
[33] |
Costs of hepatocellular carcinoma (per year) |
168,899 |
11,601 |
Gamma |
[33] |
Direct non-medical cost for complication treatment |
Costs of chronic HCV infection (per year) |
4,303 |
430.3 |
Gamma |
[33, 34] |
Costs of compensated cirrhosis (per year) |
4,216 |
421.6 |
Gamma |
[33, 34] |
Costs of decompensated cirrhosis (per year) |
5,823 |
582.3 |
Gamma |
[33, 34] |
Costs of hepatocellular carcinoma (per year) |
9,516 |
951.6 |
Gamma |
[33, 34] |